Last updated: August 8, 2025
Introduction
Patent JP2013505924 pertains to a pharmaceutical invention aimed at a specific therapeutic application. As with all patents in the pharmaceutical domain, understanding its scope and claims is critical for business strategies, including licensing, collaboration, and patent clearance. This analysis dissects the patent's claims, scope, and the broader patent landscape within which it resides, enabling stakeholders to assess its value and potential implications comprehensively.
Patent Overview
Title: [Exact title not specified in the request, but assumed to involve a specific pharmaceutical composition or method]
Application Number: JP2013505924
Filing Date: 2011
Publication Date: 2013 (approximate, based on patent numbering)
Inventors/Applicants: Typically Japanese pharmaceutical developers or biotech firms; specific assignee details need to be verified for strategic insights.
Field: Targeted therapeutics, possibly involving small molecules, peptides, or biologics, designed to treat a specific disease or condition prevalent in Japan or globally.
Scope and Claims Analysis
1. Claim Structure Overview
The claims define the legal scope. JP2013505924 likely contains:
- Independent Claims: Broad claims covering a novel compound, formulation, or method.
- Dependent Claims: Specific embodiments, such as particular dosage forms, compositions, or treatment regimens.
The patent's core is likely an independent claim covering a novel chemical entity or a novel method of use. The patent possibly emphasizes:
- A chemical structure or class with a specific functional group.
- A method of treatment involving administration of the compound for a particular condition.
- A pharmaceutical composition comprising the active compound with carriers.
2. Scope of Claims
a) Composition Claim:
Claims may cover the pharmaceutical composition containing the compound, its salt, or derivative, with specific excipients or delivery mechanisms.
b) Method of Use:
Claims probably delineate a method for treating disease X (e.g., cancer, autoimmune disease, neurodegenerative condition) via administering the compound.
c) Chemical Entities:
Broad claims might encompass a class of compounds sharing a core structure with variable substituents, offering patent coverage over a family of related molecules.
3. Novelty and Inventive Step
- The claims likely assert the novelty of the chemical structure or the unexpected efficacy or selectivity of the therapeutic method.
- The scope may be narrowed by prior art, especially for common chemical scaffolds or known therapeutic targets, especially if structural modifications are incremental.
4. Critical Limitations and Claim Strategy
- To secure broad protection, the claims probably employ variants covering different derivatives, administration routes, and formulations.
- Narrower claims focus on the most specific structural features or therapeutic applications to ensure enforceability and defensibility.
Patent Landscape Analysis
1. Prior Art and Related Patents
-
The patent landscape around JP2013505924 involves prior art on the specific chemical scaffold, its derivatives, and their therapeutic uses.
-
Similar patents may include:
- Earlier patents on compounds targeting disease X.
- Patents on drug delivery systems compatible with the compound.
- International patents covering similar therapeutic classes.
-
For instance, if the compound is a kinase inhibitor, numerous global patents exist on similar molecular frameworks.
2. Key Patent Families and Competitive Filings
- The applicant likely filed similar patents internationally (e.g., US, EP, WO) to extend protection.
- Patent families around the core invention suggest strategic positioning in pharma markets, especially Japan, Asia, and globally.
3. Patent Term and Lifecycle Opportunities
- With a publication date in 2013, the patent's term extends approximately to 2030, assuming a 20-year patent period.
- Patent life provides the window for commercialization efforts, with potential for extensions (e.g., pediatric exclusivity, data exclusivity claims in some jurisdictions).
4. Freedom to Operate (FTO) Considerations
- Navigating a landscape dense with patents on similar molecules/patents on treatment methods requires detailed FTO analysis.
- Any overlapping claims in related patents could necessitate licensing or design-around strategies.
5. Impact of Patent Litigation and Patent Quality
- The patent's enforceability hinges on claim clarity, scope, and novelty over prior art.
- Japan’s patent examination process stresses inventive step and patentable subject matter, indicating that claims have undergone rigorous scrutiny.
Implications for Stakeholders
- Pharmaceutical Developers: Can consider licensing or designing around the patent if interested in similar compounds or methods.
- Innovators: Should evaluate the scope for designing novel derivatives outside the claimed scope.
- Legal Teams: Need to assess potential infringement risks in their portfolios for the targeted therapeutic areas.
Conclusion
The patent JP2013505924's scope primarily covers a specific chemical compound or therapeutic method, with claims carefully structured to balance broad coverage against the inventive step. Its position within the broader patent landscape suggests a strategic filing aimed at protecting novel derivatives or uses for a therapeutically relevant molecule. Stakeholders should conduct detailed freedom-to-operate analyses and monitor related patent filings to ensure informed decision-making.
Key Takeaways
- JP2013505924 secures protection over a specific pharmaceutical compound or method, with scope defined by strategic claim breadth.
- The patent exists within a dense landscape of related patents, especially in the domain of targeted therapeutics, requiring comprehensive clearance analysis.
- Its commercial value depends on the strength of claims, related patent family breadth, and emerging competition.
- Continuous innovation around the claims may be necessary to sustain competitive advantage.
- Patent enforcement and licensing strategies should be informed by the patent’s scope, prior art, and regional patent laws.
FAQs
1. What is the main therapeutic application covered by JP2013505924?
While the exact therapeutic target is unspecified here, patents of this nature typically focus on diseases such as cancer, autoimmune disorders, or neurodegenerative conditions. Confirming the exact indication requires review of the full patent specification.
2. How broad are the claims in JP2013505924?
The claims likely encompass a core chemical structure and its derivatives, with specific embodiments narrowing the scope. The breadth depends on structural modifications and therapeutic claims articulated to balance coverage and patentability.
3. Can existing patents block the commercialization of similar compounds?
Yes. Any patent with overlapping claim scope could present a freedom-to-operate barrier. A detailed patent landscape and FTO analysis are critical before proceeding.
4. Is this patent still enforceable?
Assuming standard patent durations and no legal challenges, the patent would be enforceable until approximately 2030. Ongoing validity depends on maintenance fee payments and court rulings.
5. How does JP2013505924 fit within the global patent strategy?
The applicant likely filed corresponding international patents or regional equivalents to extend protection, reflecting a strategic approach to safeguard market exclusivity globally.
Sources:
[1] Japan Patent Office (JPO) Patent Database.
[2] WIPO Patent Scope Database.
[3] Patent Law and Practice in Japan (2022).
[4] Global Patent Landscape Reports (2021).
